Associate Professor, Global Health and Community Medicine, University of Washington School of Medicine
Infectious Disease
Dr. Jared M. Baeten, MD
|
|
Give Review
Jared Baeten works in the field of Infectious Disease. He went to University of Washington School of Medicine. Doctor Jared M. Baeten, MD is a published MD as well. He has 104 publications published. The latest was: An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women. Jared Baeten accepts Medicare payments and is listed with Medicare.gov.
Publications
- Reversibility of Glomerular Renal Function Decline in HIV-Uninfected Men and Women Discontinuing Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis.
- Tenofovir alafenamide for HIV: time to switch?
- Host genetic and viral determinants of HIV-1 RNA set-point among HIV-1 seroconverters from sub-Saharan Africa.
- Changes in Glomerular Kidney Function Among HIV-1-Uninfected Men and Women Receiving Emtricitabine-Tenofovir Disoproxil Fumarate Preexposure Prophylaxis: A Randomized ...
- Antiretroviral Pre-Exposure Prophylaxis Does Not Enhance Immune Responses to HIV in Exposed but Uninfected Persons.
- Initiation of antiretroviral therapy and viral suppression after home HIV testing and counselling in KwaZulu-Natal, South Africa, and Mbarara district, Uganda: a prosp...
- Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception.
- Association between male circumcision and incidence of syphilis in men and women: a prospective study in HIV-1 serodiscordant heterosexual African couples.
- Lay Social Resources for Support of Adherence to Antiretroviral Prophylaxis for HIV Prevention Among Serodiscordant Couples in sub-Saharan Africa: A Qualitative Study.
- Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-...
- High Medication Adherence During Periconception Periods Among HIV-1-Uninfected Women Participating in a Clinical Trial of Antiretroviral Pre-exposure Prophylaxis.
- Pre-exposure prophylaxis does not affect the fertility of HIV-1-uninfected men.
- Pregnancy Incidence and Outcomes Among Women Receiving Preexposure Prophylaxis for HIV Prevention: A Randomized Clinical Trial.
- Successful Discontinuation of the Placebo Arm and Provision of an Effective HIV Prevention Product After a Positive Interim Efficacy Result: The Partners PrEP Study Ex...
- Preferences for Daily or Intermittent Pre-exposure Prophylaxis Regimens and Ability to Anticipate Sex Among HIV Uninfected Members of Kenyan HIV Serodiscordant Couples.
- Delay of Antiretroviral Therapy Initiation is Common in East African HIV-Infected Individuals in Serodiscordant Partnerships.
- An intervention to support HIV pre-exposure prophylaxis (PrEP) adherence in HIV serodiscordant couples in Uganda.
- Pre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraception.
- Enhanced and efficient detection of virus-driven cytokine expression by human NK and T cells.
- HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention.
- Pre-exposure prophylaxis to intensify the fight against HIV.
- Unreported antiretroviral use by HIV-1-infected participants enrolling in a prospective research study.
- A prospective study of the effect of pregnancy on CD4 counts and plasma HIV-1 RNA concentrations of antiretroviral-naive HIV-1-infected women.
- HIV-1 subtype C is not associated with higher risk of heterosexual HIV-1 transmission: a multinational study among HIV-1 serodiscordant couples.
- 'If I am given antiretrovirals I will think I am nearing the grave': Kenyan HIV serodiscordant couples' attitudes regarding early initiation of antiretroviral therapy.
- Systemic Cytokine Levels Show Limited Correlation with Risk of HIV-1 Acquisition.
- Incident Herpes Simplex Virus Type 2 Infection Increases the Risk of Subsequent Episodes of Bacterial Vaginosis.
- Sexual behaviour of heterosexual men and women receiving antiretroviral pre-exposure prophylaxis for HIV prevention: a longitudinal analysis.
- Family planning and HIV: two steps forward....
- Adherence to Antiretroviral Prophylaxis for HIV Prevention: A Substudy Cohort within a Clinical Trial of Serodiscordant Couples in East Africa.
- Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: subgroup analyses from a randomized trial.
- Preexposure prophylaxis for HIV prevention: where have we been and where are we going?
- Integrated strategies for combination HIV prevention: principles and examples for men who have sex with men in the Americas and heterosexual African populations.
- Differential Regulatory T Cell Activity in HIV Type 1-Exposed Seronegative Individuals.
- High HIV testing uptake and linkage to care in a novel program of home-based HIV counseling and testing with facilitated referral in KwaZulu-Natal, South Africa.
- Daily Short Message Service Surveys to Measure Sexual Behavior and Pre-exposure Prophylaxis Use Among Kenyan Men and Women.
- Fertility Intentions and Interest in Early Antiretroviral Therapy Among East African HIV-1-Infected Individuals in Serodiscordant Partnerships.
- HIV-1 prevention with ART and PrEP: mathematical modeling insights into resistance, effectiveness and public health impact.
- Plasma viral loads during early HIV-1 infection are similar in subtype C- and non-subtype C-infected African seroconverters.
- Incidence and Correlates of Chlamydia trachomatis Infection in a High-Risk Cohort of Kenyan Women.
- High-dose Valacyclovir Decreases Plasma HIV-1 RNA More Than Standard-dose Acyclovir in HIV-1, HSV-2 Positive Persons: a Randomized, Crossover Trial.
- Use of Antiretrovirals for HIV Prevention: What Do We Know and What Don't We Know?
- Understanding the Potential Impact of a Combination HIV Prevention Intervention in a Hyper-Endemic Community.
- Serodiscordancy and HIV prevention in sub-Saharan Africa.
- Immune response to hepatitis B virus vaccination among HIV-1 infected and uninfected adults in Kenya.
- Hormonal contraceptive use and risk of HIV-1 disease progression.
- Antiretroviral-based HIV-1 prevention: antiretroviral treatment and pre-exposure prophylaxis.
- An empiric risk scoring tool for identifying high-risk heterosexual HIV-1 serodiscordant couples for targeted HIV-1 prevention.
- Oral antiretroviral chemoprophylaxis: current status.
- Partner characteristics predicting HIV-1 setpoint in sexually acquired HIV-1 among African seroconverters.
- Systemic and Topical Drugs for the Prevention of HIV Infection: Antiretroviral Pre-exposure Prophylaxis.
- Genital Inflammation Predicts HIV-1 Shedding Independent of Plasma Viral Load and Systemic Inflammation.
- Correlation Between Pill Counts and Biologic Effects in an HIV-1 Prevention Clinical Trial: Implications for Measuring Adherence.
- Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
- Use of hormonal contraceptives and risk of HIV-1 transmission - Authors' reply.
- The impact of early monitored management on survival in hospitalized adult Ugandan patients with severe sepsis: A prospective intervention study*
- Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral based HIV-1 prevention strategies.
- HIV-1 Prevention for HIV-1 Serodiscordant Couples.
- Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence.
- Clinical and virologic response to episodic acyclovir for genital ulcers among HIV-1 seronegative, herpes simplex virus type 2 seropositive African women: a randomized...
- High-dose Valacyclovir HSV-2 Suppression Results in Greater Reduction in Plasma HIV-1 Levels Compared With Standard Dose Acyclovir Among HIV-1/HSV-2 Coinfected Persons...
- A qualitative study of barriers to consistent condom use among HIV-1 serodiscordant couples in Kenya.
- Optimal Uses of Antiretrovirals for Prevention in HIV-1 Serodiscordant Heterosexual Couples in South Africa: A Modelling Study.
- Outside Sexual Partnerships and Risk of HIV Acquisition for HIV Uninfected Partners in African HIV Serodiscordant Partnerships.
- A prospective study of frequency and correlates of intimate partner violence among African heterosexual HIV serodiscordant couples.
- Genital HIV-1 RNA Predicts Risk of Heterosexual HIV-1 Transmission.
- Combination HIV prevention: significance, challenges, and opportunities.
- Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons.
- Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis.
- Circumcision of Male Children for Reduction of Future Risk for HIV: Acceptability among HIV Serodiscordant Couples in Kampala, Uganda.
- A Post-Trial Assessment of Factors Influencing Study Drug Adherence in a Randomized Biomedical HIV-1 Prevention Trial.
- Knowledge and attitudes about male circumcision for HIV-1 prevention among heterosexual HIV-1 serodiscordant partnerships in Kampala, Uganda.
- Adherence in HIV type 1 prevention trials.
- Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women.
- Frequent detection of human adenovirus from the lower gastrointestinal tract in men who have sex with men.
- Increased risk of genital ulcer disease in women during the first month after initiating antiretroviral therapy.
- Breadth of neutralizing antibody response to human immunodeficiency virus type 1 is affected by factors early in infection but does not influence disease progression.
- Prospective study of vaginal bacterial flora and other risk factors for vulvovaginal candidiasis.
- Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over ...
- New biomedical strategies for HIV-1 prevention in women.
- A prospective study of risk factors for bacterial vaginosis in HIV-1-seronegative African women.
- Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial.
- High Mycoplasma genitalium organism burden is associated with shedding of HIV-1 DNA from the cervix.
- A decrease in albumin in early HIV type 1 infection predicts subsequent disease progression.
- The influence of hormonal contraceptive use on HIV-1 transmission and disease progression.
- HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads.
- Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition.
- Re: distinguishing the temporal association between women's intravaginal practices and risk of human immunodeficiency virus infection: a prospective study of South Afr...
- Quantification of genital human immunodeficiency virus type 1 (HIV-1) DNA in specimens from women with low plasma HIV-1 RNA levels typical of HIV-1 nontransmitters.
- HIV-1 infection alters the retinol-binding protein:transthyretin ratio even in the absence of the acute phase response.
- Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women.
- A comparison of genital HIV-1 shedding and sexual risk behavior among Kenyan women based on eligibility for initiation of HAART according to WHO guidelines.
- Effect of contraceptive methods on natural history of HIV: studies from the Mombasa cohort.
- Female-to-male infectivity of HIV-1 among circumcised and uncircumcised Kenyan men.
- Contribution of HIV-1 infection to acquisition of sexually transmitted disease: a 10-year prospective study.
- Micronutrient supplementation increases genital tract shedding of HIV-1 in women: results of a randomized trial.
- Vitamin A supplementation and genital shedding of herpes simplex virus among HIV-1-infected women: a randomized clinical trial.
- Use of serum retinol-binding protein for prediction of vitamin A deficiency: effects of HIV-1 infection, protein malnutrition, and the acute phase response.
- Injectable contraceptive use and genital ulcer disease during the early phase of HIV-1 infection increase plasma virus load in women.
- Infection with multiple human immunodeficiency virus type 1 variants is associated with faster disease progression.
- Acyclovir Prophylaxis Reduces the Incidence of Herpes Zoster Among HIV-Infected Individuals: Results of a Randomized Clinical Trial.
- Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women.
- An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women.
Schools
University of Washington
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Choice Health PPO
- Coop Core
- Connect
- Medicaid
- Medicare MCR
- MultiPlan PPO
- Heritage Plus
- Heritage Signature
- Personal Option EPO
- Preferred Provider Network PPN
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Education
-
University of Washington -
Massachusetts General Hospital -
University of Washington School of Medicine
Drug Facts
| NPI NUMBER | 1043201684 | |
| NPPES Provider LastName | BAETEN | |
| NPPES Provider FirstName | JARED | |
| NPPES Provider ZIPCode | 981042420 | |
| NPPES Provider State | WA | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 1254.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 65.0 | |
| Percent Opioid Claims | 5.18 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1043201684 |
| Last Name Of The Provider | BAETEN |
| First Name Of The Provider | JARED |
| View All |
Similar Doctors
|
|
Dr. Gregory B. Moss, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David N. Fredricks, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christian B. Ramers, MD |
|
|
Dr. Robert C. Barnes, MD |
|
|
Dr. Heidi M. Crane, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul A. Thottingal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard A. Miller, MD |